(Q30874452)

English

Vitreous and serum levels of vascular endothelial growth factor and platelet-derived growth factor and their correlation in patients with non-proliferative diabetic retinopathy and clinically significant macula oedema.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799585%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Vitreous and serum levels of vascular endothelial growth factor and platelet-derived growth factor and their correlation in patients with non-proliferative diabetic retinopathy and clinically significant macula oedema (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799585%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

0 references

diabetic retinopathy

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799585%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Stavros A. Dimitrakos

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799585%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Anna Praidou

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799585%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Eleni Papakonstantinou

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799585%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Nikolaos Georgiadis

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799585%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

George Karakiulakis

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799585%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

1 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799585%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Acta Ophthalmologica

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799585%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

89

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799585%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799585%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

248-254

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799585%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01661.X

21 January 2018

Anti-vascular endothelial growth factor therapy for ocular neovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01661.X

21 January 2018

The pathogenesis of edema in diabetic maculopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01661.X

21 January 2018

The pathogenesis of diabetic retinopathy: old concepts and new questions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01661.X

21 January 2018

Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01661.X

21 January 2018

A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01661.X

21 January 2018

Vascular endothelial growth factor: basic science and clinical progress

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01661.X

21 January 2018

Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01661.X

21 January 2018

Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01661.X

21 January 2018

Risk evaluation of outcome of vitreous surgery for proliferative diabetic retinopathy based on vitreous level of vascular endothelial growth factor and angiotensin II.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01661.X

21 January 2018

Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01661.X

21 January 2018

Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01661.X

21 January 2018

Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01661.X

21 January 2018

Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01661.X

21 January 2018

Platelet-derived growth factor-BB: a survival factor for the retinal microvasculature during periods of metabolic compromise

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01661.X

21 January 2018

Intravitreal bevacizumab (Avastin) in proliferative diabetic retinopathy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01661.X

21 January 2018

A comparative debate on the various anti-vascular endothelial growth factor drugs: pegaptanib sodium (Macugen), ranibizumab (Lucentis) and bevacizumab (Avastin).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01661.X

21 January 2018

Vitreous and serum levels of platelet-derived growth factor and their correlation in patients with proliferative diabetic retinopathy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01661.X

21 January 2018

Optical coherence tomography and vessel diameter changes after intravitreal bevacizumab in diabetic macular oedema

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01661.X

21 January 2018

Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2009.01661.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30874452&oldid=1954500538"